{
    "nct_id": "NCT05004688",
    "title": "An Open-label Trial to Evaluate the Effects of BCG Immunization on Biomarkers of Inflammation/Immune Response and Alzheimer's Disease in Adults With Mild Cognitive Impairment and Mild-to-Moderate Dementia Due to Alzheimer's Disease",
    "status": "COMPLETED",
    "last_update_time": "2025-03-26",
    "description_brief": "A study of the effects of Bacillus Calmette-Gu\u00e9rin (BCG) immunization on cerebrospinal fluid and blood-based biomarkers in older with mild cognitive impairment and mild-to-moderate to Alzheimer's disease.",
    "description_detailed": "This single-site, open-label trial will investigate the effects of BCG vaccination on IIR and AD biofluid biomarkers, magnetic resonance imaging (MRI) biomarkers, and neurocognitive/behavioral functioning over a one year period in older adults with mild cognitive impairment (MCI) to mild-to-moderate dementia due to AD. This study will also gather data on tolerability and safety.",
    "phase": [
        "PHASE2"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "OTHER",
    "results": {
        "participantFlowModule": {
            "groups": [
                {
                    "id": "FG000",
                    "title": "Active BCG Immunization",
                    "description": "Active BCG immunization\n\nBiological/Vaccine: Bacillus Calmette-Guerin (BCG): Two Bacillus Calmette-Gu\u00e9rin (Japan BCG) vaccine injections spaced four week apart. Each injection will have 0.36-3.9 x 10\\^6 colony forming units (CFU) reconstituted in 0.1 mL saline."
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "15"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "4"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "11"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Protocol Violation",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "7"
                                }
                            ]
                        },
                        {
                            "type": "Physician Decision",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "2"
                                }
                            ]
                        },
                        {
                            "type": "Withdrawal by Subject",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "2"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "Active BCG Immunization",
                    "description": "Active BCG immunization\n\nBiological/Vaccine: Bacillus Calmette-Guerin (BCG): Two Bacillus Calmette-Gu\u00e9rin (Japan BCG) vaccine injections spaced four week apart. Each injection will have 0.36-3.9 x 10\\^6 colony forming units (CFU) reconstituted in 0.1 mL saline."
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "15"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Categorical",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "<=18 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Between 18 and 65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "5"
                                        }
                                    ]
                                },
                                {
                                    "title": ">=65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "10"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "9"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "15"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "CSF Collected",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "7"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Blood Collected",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "7"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Cognitive testing measured",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "7"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Blood Biomarkers of Pharmacodynamic Response- Cytokines",
                    "description": "Change in concentration (Average difference) of circulating cytokines in blood from baseline (Average difference).Cytokines include: Plasma IFN-g (pg/ml), Plasma IL-1b (pg/ml), Plasma IL-2 (pg/ml), Plasma IL-6 (pg/ml), Plasma IL-10 (pg/ml), Plasma TNF-a (pg/ml).\n\nMean differences (and standard deviations) from baseline values are presented for the Day 364 (end of study) sample collections for the 4 participants in the study.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "picogram/milliliter (pg/ml)",
                    "timeFrame": "Baseline to Day 364",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active BCG Immunization",
                            "description": "Biological/Vaccine: Bacillus Calmette-Guerin (BCG): Two Bacillus Calmette-Gu\u00e9rin (Japan BCG) vaccine injections spaced four week apart. Each injection will have 0.36-3.9 x 10\\^6 colony forming units (CFU) reconstituted in 0.1 mL saline."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "4"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Plasma IFN-g (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "26.672",
                                            "spread": "125.864"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Plasma IL-1b (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "190.829",
                                            "spread": "181.329"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Plasma IL-2 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "20.309",
                                            "spread": "19.205"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Plasma IL-6 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2293.879",
                                            "spread": "4308.539"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Plasma IL-10 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "366.090",
                                            "spread": "656.157"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Plasma TNF-a (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "53.903",
                                            "spread": "54.002"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "CSF Biomarkers of Pharmacodynamic Response- Cytokines",
                    "description": "Change in concentration (Average difference) of circulating cytokines in CSF from baseline (Average difference). Cytokines measured include: CSF IFN-g (pg/ml), CSF IL-1b (pg/ml), CSF IL-2 (pg/ml), CSF IL-6 (pg/ml), CSF IL-10 (pg/ml), CSF TNF-a (pg/ml).\n\nMean differences (and standard deviations) from baseline values are presented for the Day 84 sample collections for the 7 participants with complete data in the study.",
                    "populationDescription": "Since this outcome was analyzing the average difference between Day 0 and Day 84, there were more participants enrolled for these times points than when comparing Day 0 to Day 364. 15 participants started the trial, and only 4 completed, thus there were 7 active participants for the Day 84 timepoint.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "picogram/milliliter (pg/ml)",
                    "timeFrame": "Baseline to Day 84",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active BCG Immunization",
                            "description": "Biological/Vaccine: Bacillus Calmette-Guerin (BCG): Two Bacillus Calmette-Gu\u00e9rin (Japan BCG) vaccine injections spaced four week apart. Each injection will have 0.36-3.9 x 10\\^6 colony forming units (CFU) reconstituted in 0.1 mL saline."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "7"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "CSF IFN-g (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.053",
                                            "spread": "13.002"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF IL-1b (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.287",
                                            "spread": "15.192"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF IL-2 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "8.103",
                                            "spread": "20.326"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF IL-6 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "21.009",
                                            "spread": "1220.991"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF IL-10 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-3.057",
                                            "spread": "80.133"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF TNF-a (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.396",
                                            "spread": "11.426"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "CSF Biomarkers of Pharmacodynamic Response- Cytokines",
                    "description": "Change in concentration (Average Difference) of circulating cytokines in CSF from baseline. Cytokines measured include: CSF IFN-g (pg/ml), CSF IL-1b (pg/ml), CSF IL-2 (pg/ml), CSF IL-6 (pg/ml), CSF IL-10 (pg/ml), CSF TNF-a (pg/ml).\n\nMean differences (and standard deviations) from baseline values are presented for the Day 364 (end of study) sample collections for the 4 participants with complete data in the study.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "picogram/milliliter (pg/ml)",
                    "timeFrame": "Baseline to Day 364",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active BCG Immunization",
                            "description": "Biological/Vaccine: Bacillus Calmette-Guerin (BCG): Two Bacillus Calmette-Gu\u00e9rin (Japan BCG) vaccine injections spaced four week apart. Each injection will have 0.36-3.9 x 10\\^6 colony forming units (CFU) reconstituted in 0.1 mL saline."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "4"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "CSF IFN-g (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-14.368",
                                            "spread": "13.773"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF IL-1b (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "5.510",
                                            "spread": "10.867"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF IL-2 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-12.910",
                                            "spread": "22.841"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF IL-6 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "710.455",
                                            "spread": "1827.730"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF IL-10 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-95.078",
                                            "spread": "144.162"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF TNF-a (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.300",
                                            "spread": "19.083"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Blood Biomarkers of AD Pathology-ATN",
                    "description": "Change in concentration (Average difference) of ATN markers of AD pathophysiology phospho-tau (217 and 181) and neurofilament light protein biomarkers in blood from baseline.\n\nMean differences (and standard deviations) from baseline values are presented for the Day 364 (end of study) sample collections for the 4 participants in the study at this timepoint.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "picogram/milliliter (pg/ml)",
                    "timeFrame": "Baseline to Day 364",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active BCG Immunization",
                            "description": "Biological/Vaccine: Bacillus Calmette-Guerin (BCG): Two Bacillus Calmette-Gu\u00e9rin (Japan BCG) vaccine injections spaced four week apart. Each injection will have 0.36-3.9 x 10\\^6 colony forming units (CFU) reconstituted in 0.1 mL saline."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "4"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Plasma pTau217 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.392",
                                            "spread": "5.382"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Plasma pTau181 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.233",
                                            "spread": "0.362"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Plasma NfL (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.852",
                                            "spread": "5.810"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "CSF Biomarkers of AD Pathology-ATN",
                    "description": "Change in concentration (Average difference) of ATN markers of AD pathophysiology (phospho-tau181, total tau, and neurofilament light protein biomarkers in CSF from baseline.\n\nMean differences (and standard deviations) from baseline values are presented Day 364 (end of study) sample collections for the 4 participants in the study at this timepoint.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "picogram/milliliter (pg/ml)",
                    "timeFrame": "Baseline to Day 364",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active BCG Immunization",
                            "description": "Biological/Vaccine: Bacillus Calmette-Guerin (BCG): Two Bacillus Calmette-Gu\u00e9rin (Japan BCG) vaccine injections spaced four week apart. Each injection will have 0.36-3.9 x 10\\^6 colony forming units (CFU) reconstituted in 0.1 mL saline."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "4"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "CSF tTau (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-3.595",
                                            "spread": "26.970"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF pTau181 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-5.955",
                                            "spread": "10.135"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF NfL (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-55.413",
                                            "spread": "477.315"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Blood Biomarkers of AD Pathology-ATN",
                    "description": "Change in concentration (Average difference) of ATN markers of AD pathophysiology (phospho-tau (217 and 181) and neurofilament light protein biomarkers in blood from baseline.\n\nMean differences (and standard deviations) from baseline values are presented for the Day 84 sample collections for the 7 participants in the study at this timepoint.",
                    "populationDescription": "Since this outcome was analyzing the average difference between Day 0 and Day 84, there were more participants enrolled for these times points than when comparing Day 0 to Day 364. 15 participants started the trial, and only 4 completed, thus there were 7 active participants for the Day 84 timepoint.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "picogram/milliliter (pg/ml)",
                    "timeFrame": "Baseline to Day 84",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active BCG Immunization",
                            "description": "Biological/Vaccine: Bacillus Calmette-Guerin (BCG): Two Bacillus Calmette-Gu\u00e9rin (Japan BCG) vaccine injections spaced four week apart. Each injection will have 0.36-3.9 x 10\\^6 colony forming units (CFU) reconstituted in 0.1 mL saline."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "7"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Plasma pTau217 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.916",
                                            "spread": "7.179"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Plasma pTau181 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.004",
                                            "spread": "1.288"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Plasma NfL (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.735",
                                            "spread": "7.881"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "CSF Biomarkers of AD Pathology-ATN",
                    "description": "Change in concentration (Average difference) of ATN markers of AD pathophysiology (phospho-tau181, total tau, and neurofilament light protein biomarkers in CSF from baseline.\n\nMean differences (and standard deviations) from baseline values are presented for the Day 84 sample collections for the 4 participants in the study at this timepoint.",
                    "populationDescription": "Since this outcome was analyzing the average difference between Day 0 and Day 84, there were more participants enrolled for these times points than when comparing Day 0 to Day 364. 15 participants started the trial, and only 4 completed, thus there were 7 active participants for the Day 84 timepoint.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "picogram/milliliter (pg/ml)",
                    "timeFrame": "Baseline to Day 84",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active BCG Immunization",
                            "description": "Biological/Vaccine: Bacillus Calmette-Guerin (BCG): Two Bacillus Calmette-Gu\u00e9rin (Japan BCG) vaccine injections spaced four week apart. Each injection will have 0.36-3.9 x 10\\^6 colony forming units (CFU) reconstituted in 0.1 mL saline."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "7"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "CSF tTau (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "8.727",
                                            "spread": "49.826"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF pTau181 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-2.414",
                                            "spread": "11.793"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF NfL (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-103.161",
                                            "spread": "317.523"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Cognitive Measures (RBANS)",
                    "description": "Change in Total Scale Index (TSI) of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Mean differences and standard deviations are expressed for the difference between the Day 84 TSI and the baseline TSI for the 7 participants in the study.\n\nThe RBANS is an assessment commonly used in clinical trials to assess cognitive functioning. Scores range from 40 to 160 with lower scores indicating poorer performance, thus a score decrease would indicate a decrease in cognitive performance. A score under 78 is typically indicative of cognitive impairment.",
                    "populationDescription": "Since this outcome was analyzing the average difference between Day 0 and Day 84, there were more participants enrolled for these times points than when comparing Day 0 to Day 364. 15 participants started the trial, and only 4 completed, thus there were 7 active participants for the Day 84 timepoint.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "Baseline to Day 84",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active BCG Immunization",
                            "description": "Biological/Vaccine: Bacillus Calmette-Guerin (BCG): Two Bacillus Calmette-Gu\u00e9rin (Japan BCG) vaccine injections spaced four week apart. Each injection will have 0.36-3.9 x 10\\^6 colony forming units (CFU) reconstituted in 0.1 mL saline."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "7"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "17.710",
                                            "spread": "35.127"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Cognitive Measures (RBANS)",
                    "description": "Change in Total Scale Index (TSI) of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Mean differences and standard deviations are expressed for the difference between the end of study TSI and the baseline TSI for the 4 participants in the study.\n\nThe RBANS is an assessment commonly used in clinical trials to assess cognitive functioning. Scores range from 40 to 160 with lower scores indicating poorer performance, thus a score decrease would indicate a decrease in cognitive performance. A score under 78 is typically indicative of cognitive impairment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "Baseline to Day 364",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active BCG Immunization",
                            "description": "Biological/Vaccine: Bacillus Calmette-Guerin (BCG): Two Bacillus Calmette-Gu\u00e9rin (Japan BCG) vaccine injections spaced four week apart. Each injection will have 0.36-3.9 x 10\\^6 colony forming units (CFU) reconstituted in 0.1 mL saline."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "4"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-5.667",
                                            "spread": "19.075"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Amyloid-\u03b242/40 Average Difference in Blood",
                    "description": "Average difference of ATN markers of AD pathophysiology (Amyloid-\u03b242/40 ratio) in blood from baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "ratio",
                    "timeFrame": "Baseline to Day 364",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active BCG Immunization",
                            "description": "Biological/Vaccine: Bacillus Calmette-Guerin (BCG): Two Bacillus Calmette-Gu\u00e9rin (Japan BCG) vaccine injections spaced four week apart. Each injection will have 0.36-3.9 x 10\\^6 colony forming units (CFU) reconstituted in 0.1 mL saline."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "4"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.001",
                                            "spread": "0.06"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Amyloid-\u03b242/40 Average Difference in CSF",
                    "description": "Average difference of ATN markers of AD pathophysiology (Amyloid-\u03b242/40) in CSF from baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "ratio",
                    "timeFrame": "Baseline to Day 364",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active BCG Immunization",
                            "description": "Biological/Vaccine: Bacillus Calmette-Guerin (BCG): Two Bacillus Calmette-Gu\u00e9rin (Japan BCG) vaccine injections spaced four week apart. Each injection will have 0.36-3.9 x 10\\^6 colony forming units (CFU) reconstituted in 0.1 mL saline."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "4"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.000",
                                            "spread": "0.002"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Amyloid-\u03b242/40 Average Difference in Blood - Baseline to Day 84",
                    "description": "Average difference of ATN markers of AD pathophysiology (Amyloid-\u03b242/40) in blood from baseline.",
                    "populationDescription": "Since this outcome was analyzing the average difference between Day 0 and Day 84, there were more participants enrolled for these times points than when comparing Day 0 to Day 364. 15 participants started the trial, and only 4 completed, thus there were 7 active participants for the Day 84 timepoint.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "ratio",
                    "timeFrame": "Baseline to Day 84",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active BCG Immunization",
                            "description": "Biological/Vaccine: Bacillus Calmette-Guerin (BCG): Two Bacillus Calmette-Gu\u00e9rin (Japan BCG) vaccine injections spaced four week apart. Each injection will have 0.36-3.9 x 10\\^6 colony forming units (CFU) reconstituted in 0.1 mL saline."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "7"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.001",
                                            "spread": "0.005"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Amyloid-\u03b242/40 Average Difference in CSF - Baseline to Day 84",
                    "description": "Average difference of ATN markers of AD pathophysiology (Amyloid-\u03b242/40) in CSF from baseline.",
                    "populationDescription": "Since this outcome was analyzing the average difference between Day 0 and Day 84, there were more participants enrolled for these times points than when comparing Day 0 to Day 364. 15 participants started the trial, and only 4 completed, thus there were 7 active participants for the Day 84 timepoint.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "ratio",
                    "timeFrame": "Baseline to Day 84",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active BCG Immunization",
                            "description": "Biological/Vaccine: Bacillus Calmette-Guerin (BCG): Two Bacillus Calmette-Gu\u00e9rin (Japan BCG) vaccine injections spaced four week apart. Each injection will have 0.36-3.9 x 10\\^6 colony forming units (CFU) reconstituted in 0.1 mL saline."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "7"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.001",
                                            "spread": "0.001"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Blood Biomarkers of Pharmacodynamic Response - Cytokines",
                    "description": "Change in concentration of circulating cytokines in blood plasma from baseline. Cytokines include: Plasma IFN-g (pg/ml), Plasma IL-1b (pg/ml), Plasma IL-2 (pg/ml), Plasma IL-6 (pg/ml), Plasma IL-10 (pg/ml), Plasma TNF-a (pg/ml). Mean differences (and standard deviations) from baseline values are presented for the Day 84 sample collections for the 7 participants in the study at that time.",
                    "populationDescription": "Since this outcome was analyzing the average difference between Day 0 and Day 84, there were more participants enrolled for these times points than when comparing Day 0 to Day 364. 15 participants started the trial, and only 4 completed, thus there were 7 active participants for the Day 84 timepoint.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "picograms/mililiter (pg/ml)",
                    "timeFrame": "Baseline to Day 84",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active BCG Immunization",
                            "description": "Biological/Vaccine: Bacillus Calmette-Guerin (BCG): Two Bacillus Calmette-Gu\u00e9rin (Japan BCG) vaccine injections spaced four week apart. Each injection will have 0.36-3.9 x 10\\^6 colony forming units (CFU) reconstituted in 0.1 mL saline."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "7"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Plasma IFN-g (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "365.612",
                                            "spread": "926.852"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Plasma IL-1b (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-24.320",
                                            "spread": "100.242"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Plasma IL-2 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.460",
                                            "spread": "48.615"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Plasma IL-6 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-530.279",
                                            "spread": "1926.387"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Plasma IL-10 (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "97.486",
                                            "spread": "269.749"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Plasma TNF-a (pg/ml)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "12.004",
                                            "spread": "151.302"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "0",
            "timeFrame": "AEs were collected starting at screening through Day 364 Visit for each participant.",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Active BCG Immunization",
                    "description": "Active BCG immunization\n\nBiological/Vaccine: Bacillus Calmette-Guerin (BCG): Two Bacillus Calmette-Gu\u00e9rin (Japan BCG) vaccine injections spaced four week apart. Each injection will have 0.36-3.9 x 10\\^6 colony forming units (CFU) reconstituted in 0.1 mL saline.",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 15,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 15,
                    "otherNumAffected": 1,
                    "otherNumAtRisk": 15
                }
            ],
            "otherEvents": [
                {
                    "term": "Elevated Blood Pressure",
                    "organSystem": "Vascular disorders",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 15
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictiveAgreement": false
            },
            "pointOfContact": {
                "title": "Kayla McEachern",
                "organization": "Mass General",
                "email": "kmceachern2@mgh.harvard.edu",
                "phone": "617 643 5265"
            }
        }
    },
    "target_category": "disease-targeted biologic",
    "drug": [
        "Bacillus Calmette-Gu\u00e9rin (BCG) vaccine"
    ],
    "placebo": [],
    "explanation_target": [
        "Reason: The trial tests BCG immunization (a biological/vaccine intervention) in people with MCI to mild\u2011to\u2011moderate AD to evaluate effects on CSF and blood AD biomarkers and immune/inflammatory markers \u2014 i.e., an attempt to modify disease\u2011related biology rather than only treat symptoms. \ue200cite\ue202turn0search2\ue202turn0search5\ue201",
        "Act: Key extracted details \u2014 intervention = Bacillus Calmette\u2011Gu\u00e9rin (BCG) vaccine (two Japan\u2011BCG injections, open\u2011label single\u2011group Phase 2 trial). The protocol explicitly lists BCG as a biological/vaccine and the study objective is to measure effects on inflammation/immune response and AD biofluid biomarkers. \ue200cite\ue202turn0search2\ue202turn0search5\ue201",
        "Act (drug background): BCG is a live attenuated Mycobacterium bovis vaccine used for tuberculosis prevention; it has broad immunomodulatory/trained\u2011immunity effects that are being investigated for non\u2011TB indications (including potential effects on neuroinflammation and dementia). \ue200cite\ue202turn0search1\ue202turn0search6\ue201",
        "Act (supporting evidence): Preclinical and epidemiologic studies report that BCG can alter neuroinflammation and cognitive outcomes in AD models and is associated with lower dementia risk in some cohorts \u2014 evidence motivating clinical biomarker studies. \ue200cite\ue202turn0search3\ue202turn0search4\ue201",
        "Reflect: Classification rationale \u2014 although BCG is not an anti\u2011amyloid or anti\u2011tau monoclonal antibody, it is a biologic (vaccine) being repurposed to alter disease biology (immune/inflammatory pathways and AD biomarkers). That fits the definition of a \"disease\u2011targeted biologic\" better than the other categories (not a small molecule, not purely a symptomatic cognitive enhancer, and not focused on neuropsychiatric symptoms). Note ambiguity: BCG is an immunomodulator rather than a pathology\u2011specific vaccine, so some may view it as an immune\u2011modifying therapy rather than a classic amyloid/tau\u2011targeted biologic. \ue200cite\ue202turn0search2\ue202turn0search3\ue201"
    ],
    "agent_type": "F) Inflammation",
    "explanation_agent": [
        "Reason: The intervention is Bacillus Calmette\u2013Gu\u00e9rin (BCG) vaccination being tested to modify immune/inflammatory responses and AD-related biofluid biomarkers in people with MCI to mild\u2013moderate AD; the study objective is explicitly measuring inflammation/immune markers and CSF/plasma AD biomarkers, indicating a disease-modifying, immune-focused approach. \ue200cite\ue202turn0search0\ue201",
        "Act: Extracted details \u2014 intervention = BCG (live attenuated Mycobacterium bovis) given intradermally (two injections in the protocol described); the vaccine is known to induce trained innate immunity (NOD2-dependent epigenetic reprogramming of monocytes) and to alter cytokine responses (e.g., increased IL\u20111\u03b2, TNF, IL\u20116) and macrophage activation \u2014 immunomodulatory mechanisms motivating trials in neuroinflammation and dementia. \ue200cite\ue202turn0search2\ue202turn0search1\ue201",
        "Act (supporting evidence): Epidemiologic and clinical/preclinical work links BCG exposure/therapy with lower dementia risk and with biologic effects on peripheral and central immune measures, motivating biomarker trials in AD. \ue200cite\ue202turn0search3\ue202turn0search5\ue201",
        "Reflect: Classification rationale \u2014 the primary biological focus is modulation of immune/inflammatory pathways (neuroimmune axis/trained immunity) rather than direct targeting of amyloid, tau, synapses, vasculature, or metabolism. Therefore the most specific CADRO match is F) Inflammation. Note ambiguity: BCG is a broad immunomodulator rather than a single cytokine or receptor antagonist; some may view it as multi-modal, but the trial\u2019s stated aims and mechanistic rationale center on immune/inflammatory modulation. \ue200cite\ue202turn0search4\ue202turn0search0\ue201",
        "Output: F) Inflammation \u2014 The trial tests the BCG vaccine as an immunomodulatory/trained\u2011immunity intervention to alter immune/inflammatory pathways and AD biomarkers, which aligns with CADRO category F (Inflammation)."
    ]
}